(Q26830207)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

1 reference

title

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Gregor Hoermann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hanneke C Kluin-Nelemans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Olivier Hermine

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Patrice Dubreuil

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Karin Hartmann

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Nicholas Cross

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Andrés García-Montero

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Massimo Triggiani

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Peter Valent

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

17

A Orfao

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

M Arock

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

K Sotlar

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Broesby-Olsen

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

L Escribano

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

T K Kristensen

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

W R Sperr

11

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Gotlib

13

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Schwaab

18

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

H-P Horny

20

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

D D Metcalfe

21

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Reiter

22

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

T Haferlach

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

4 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

29

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1223-1232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes

29 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Mutation D816V alters the internal structure and dynamics of c-KIT receptor cytoplasmic region: implications for dimerization and activation mechanisms

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

A standardized framework for the validation and verification of clinical molecular genetic tests

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Primary mast cell disorders in children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Mast cells and mastocytosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Cutaneous mastocytosis: a review focusing on the pediatric population

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Recent advances in the understanding of mastocytosis: the role of KIT mutations.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Sensitive detection of KIT D816V in patients with mastocytosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

The human mast cell: an overview

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

The European Competence Network on Mastocytosis (ECNM).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Mastocytosis: pathology, genetics, and current options for therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Familial cutaneous mastocytosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Diagnostic criteria and classification of mastocytosis: a consensus proposal

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Gastrointestinal abnormalities and involvement in systemic mastocytosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Tissue mast cells in health and disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Spleen findings in generalized mastocytosis. A clinicopathologic study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Bone marrow findings in systemic mastocytosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Effects of mutant c-kit in early myeloid cells.

31 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Molecular defects in mastocytosis: KIT and beyond KIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

SNPs in KIT and KITLG genes may be associated with oligospermia in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Cladribine therapy for systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

c-kit mutational analysis in paraffin material.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

The liver, spleen, and lymph nodes in mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Molecular basis of mast cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Comprehensive mutational profiling in advanced systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

Novel R634W c-kit mutation identified in familial mastocytosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4522520

Identification of a polymorphism in the transmembrane domain of the protooncogene c-kit in healthy subjects

28 November 2018

1 reference

12 December 2020

Pathology of the lymph node and spleen in systemic mast cell disease

1 reference

12 December 2020

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

1 reference

12 December 2020

Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis

1 reference

12 December 2020

Dermoscopic features of skin lesions in patients with mastocytosis

1 reference

12 December 2020

KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients

1 reference

12 December 2020

Systemic mast cell disease with marrow and splenic involvement associated with chronic myelomonocytic leukemia

1 reference

12 December 2020

A c-kit mutation in exon 18 in familial mastocytosis

1 reference

12 December 2020

Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13)

1 reference

12 December 2020

Different patterns of spleen involvement in systemic and malignant mastocytosis. A histological and immunohistochemical study of three cases

1 reference

12 December 2020

Not all c-kit mutations can be corrected by imatinib

1 reference

12 December 2020

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

1 reference

12 December 2020

Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.24

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/LEU.2015.24

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 February 2020

1039972295

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25650093%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

25650093

2 references